ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Mathematics explains why Crispr-Cas9 sometimes cuts the wrong DNA – Phys.Org

Mathematics explains why Crispr-Cas9 sometimes cuts the wrong DNAPhys.OrgThe discovery of the Cas9 protein has simplified gene editing, and may even make it possible to eliminate many hereditary diseases in the near future. Using Cas9, researchers have… Continue reading

2018-02-07 Michael Zand NEWS

Scientists make it possible to rank the risk of resistance genes – Phys.Org

Phys.OrgScientists make it possible to rank the risk of resistance genesPhys.OrgThe researchers exploited synthetic biology to sample a large mechanistic diversity of resistance genes to investigate the impact of gene transfer on a new bacterial host. … Continue reading

2018-02-07 Michael Zand NEWS

No safety concerns so far in Sangamo’s groundbreaking gene-editing trial – pharmaphorum

Continue reading

2018-02-07 Michael Zand NEWS

Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster – Labiotech.eu (blog)

Labiotech.eu (blog)Scottish CAR-T Biotech Adds Another Stellar Partner to Its RosterLabiotech.eu (blog)No financial details were disclosed, but the biotech says it validates the potential of its gamma-delta T cell-based platform to earn over the compan… Continue reading

2018-02-07 Michael Zand NEWS

Groundbreaking gene therapies in store – ModernMedicine

ModernMedicineGroundbreaking gene therapies in storeModernMedicineSeagle says new gene therapy products are expected to be introduced in the next few years, enabling the patient to produce their own clotting factors, and to maintain the factors the pat… Continue reading

2018-02-07 Michael Zand NEWS

A&M and Celltex partner on stem cell Alzheimer’s research – Houston Chronicle


pharmaphorum

No safety concerns so far in Sangamo’s groundbreaking gene-editing trial
pharmaphorum
The trial of Sangamo’s gene-editing treatment for a rare and debilitating disease has got off to a good start, with no safety concerns reported so far. The groundbreaking trial hit the headlines around the world in November when Brian Madeux …

and more »

Continue reading

2018-02-07 Michael Zand NEWS

A&M and Celltex partner on stem cell Alzheimer’s research – Houston Chronicle


Houston Chronicle

A&M and Celltex partner on stem cell Alzheimer’s research
Houston Chronicle
Under a new state law that sanctions experimental stem cell therapy in Texas, Celltex hopes to again begin providing its stem cells to doctors and hospitals in the state, said Eller. Celltex, he said, is waiting on rules being drawn up by the Texas …
Texas A&M Institute for Regenerative Medicine and Celltex Therapeutics Enter Agreement for Alzheimer’s ResearchBusiness Wire (press release)

all 4 news articles »

Continue reading

2018-02-07 Michael Zand NEWS

Second man has gene editing in California as therapy raises no safety flags so far on first one – The Japan Times


Houston Chronicle

A&M and Celltex partner on stem cell Alzheimer’s research
Houston Chronicle
Under a new state law that sanctions experimental stem cell therapy in Texas, Celltex hopes to again begin providing its stem cells to doctors and hospitals in the state, said Eller. Celltex, he said, is waiting on rules being drawn up by the Texas …

Continue reading

2018-02-07 Michael Zand NEWS
  • 1
  • …
  • 564
  • 565
  • 566
  • 567
  • 568
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

The Japan Times

Second man has gene editing in California as therapy raises no safety flags so far on first one
The Japan Times
Madeux also had a severe cough and a partially collapsed lung, but these were deemed unrelated to the gene therapy because he had had similar problems previously. Importantly, there were no signs of harm to his liver. “That’s the big worry” because …

and more »